Twist Bioscience develops innovative enzymatic DNA synthesis process

By The Science Advisory Board staff writers

January 11, 2022 -- Twist Bioscience has developed an innovative, low-cost, scarless, and scalable enzymatic DNA synthesis process. With these comprehensive capabilities in synthesis, Twist offers multiple approaches to serve the growing number of markets leveraging synthetic DNA, the company said.

Scientists at Twist have worked for the past 18 months to develop a novel approach to synthesize strands of DNA enzymatically. Twist has developed novel enzyme/nucleotide conjugates that drastically reduce the quantity of nucleotide triphosphate used by traditional enzymatic approaches, which significantly reduces the cost and offers a much more sustainable method of synthesis, Twist said.

In addition, the link between the enzyme and the nucleotide developed by Twist maintains the integrity of the DNA, with no "scars" on the nucleobase from linker molecules. This allows the resulting enzymatically created synthetic DNA strand to be used interchangeably with naturally occurring DNA.

Emily Leproust, PhD, CEO and co-founder of Twist unveiled the advancement during her presentation at the 40th Annual J.P. Morgan Healthcare Conference.

Twist also announced that it is enabling next-generation sequencing workflows for PacBio and Singular Genomics. Twist has customized its target enrichment and library preparation workflows for both sequencing platforms to allow customers to experience the uniformity of the Twist Bioscience solution, the company said.

Twist Bioscience launches 96-plex library prep kit
Twist Bioscience has released the Twist 96-Plex Library Prep Kit, a high-performance, cost-effective preparation kit for next-generation sequencing.
Twist launches new biotech firm
Twist Bioscience has launched a new biotechnology firm, Revelar Biotherapeutics, to develop and market an antibody discovered by Twist that neutralizes...
Twist launches exome panel for genomics research
Twist Bioscience has launched Exome 2.0, an exome panel for genomics research.
Twist Bioscience, Broad Institute partner
Twist Bioscience and the Broad Institute have created a custom next-generation sequencing target enrichment exome panel to be used to research cancer...

Copyright © 2022

Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter